abnormal lipid metabolism
Conditions
Sponsors
Shonan Keiiku Hospital
Keio University, Graduate School of Media and Governance
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. A patient whose total cholesterol level is over 230 mg/dL, or LDL-colesterol level is over140mg/dL 2. A patient who attended nutritional guidance 4 weeks or more before starting this study
Exclusion criteria
Exclusion criteria: 1. A patient who is taking any drugs affecting lipid metabolism 2. A patient who cannot stop any supplements health food affecting lipid metabolism 3. A patient who is pregnant, or may become pregnant, or desire to get pregnant 4. A patient who has or had serious diseases in heart, liver, kidney, gastrointestinal tract, etc. 5. A patient who has allergy for any drugs or food 6. A patient who has or had drug or alcohol dependence 7. A patient who is judged to be unsuitable for this study by the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in LDL-cholesterol level in the patients whose LDL-cholesterol level is higher than normal range at 12 weeks after taking burdock sprout extract. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of liver function, other kinds of serum lipid level, blood glucose level, and other cytokine and adipokine levels such as leptin and tumor necrosis factor-alpha in the patients whose LDL-cholesterol level is higher than normal range at 4 and 12 weeks after taking burdock sprout extract, and Fib-4 index | — |
Countries
Japan
Contacts
Public ContactKenji Miyazaki
Shonan Keiiku Hospital Office
Outcome results
None listed